Aclaris Therapeutics Inc (ACRS) support and resistance · rev $3.6M
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
This page maps Aclaris Therapeutics Inc (ACRS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
ACRS currently screens at market cap $615.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ACRS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ACRS quote page for the session range and the stock page for the full model.
Not investment advice.